Volume-regulated outwardly rectifying anion channel (VRAC) plays an important role in cellvolume regulation in many types of cells. Little is known about the regulation of VRAC by phosphatidylinositides (PIs), which include phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2). We examined the effect of PIs on the VRAC current activated in hypotonic solution in mouse ventricular cells. VRAC current was inhibited strongly by intracellular application of LY294002 (a phosphatidylinositol 3-kinase (PI3K) inhibitor) or anti-PIP3 antibody (PIP3-Ab), and less strongly by anti-PIP2 antibody (PIP2-Ab). LY294002 inhibited regulatory volume decrease in hypotonically swollen cells, which was in parallel with the VRAC inhibition. Intracellular PIP3 or PIP2 influenced neither the basal background current in isotonic solution nor the VRAC current in hypotonic solution. However, PIP3, but not PIP2, restored the VRAC current suppressed by LY294002 or PIP2-Ab. These results suggest that the activation of VRAC current requires the presence of intracellular PIP3, that PI3K-mediated increase in PIP3 level is sufficient to fully activate VRAC current, and that PIP3 alone without osmotic stimulation cannot induce VRAC current. We propose that VRAC in mouse ventricular cells is regulated by PIP3 and/or its down stream signaling pathways.
Over the past decade, it has been shown that several types of membrane transporters and channels bind and directly and/or indirectly respond to phosphatidylinositides (PIs), including phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2) (14, 27) . Phosphoinositide 3-kinases (PI3Ks) are enzymes that phosphorylate the 3'-OH position of PIP2 inositol ring to generate PIP3, which activates many downstream effectors by binding to a domain of cellular proteins, such as pleckstrin homology domain (6, 10) . PI3K activation enhances cell survival and antagonizes apoptosis in many cell types including cardiomyocytes (1, 34) . Volume-regulated outwardly rectifying anion channel (VRAC), which exists in many types of cells, is one of the functionally important membrane anion channels (15, 17, 24) . The VRAC contributes to the regulation of cell-volume, and the cell-volume regulation is an essential cellular function coupled to a variety of physiological processes, such as cell proliferation, differentiation, migration and apoptosis, in most animal cell types (23, 24) . In particular, the VRAC current may contribute also to arrhythmogenesis in myocardial injury, cardiac ischemic preconditioning and the adaptive remodeling of the heart during myocardial hypertrophy and heart failure (9) . The intracellular mechanism underlying the activation of VRAC is not fully understood. Recent studies done on various types of cells have shown that an increase in cell-volume, which activates VRAC current, is accompanied by activation of currents were filtered at a frequency of 2.5 kHz, and sampled at 5 kHz with a Digidata 1322A and pCLAMP 9.2 software (Axon Instruments). A 3 M KCl-agar bridge was placed between the bath and the Ag-AgCl reference electrode to minimize changes in liquid junction potential. VRAC current recordings were made by applying voltage pulses of 400 ms duration to various potentials (between −100 and +100 mV in +20 mV steps) from a holding potential of −40 mV every 2 s. The access resistance of the patch electrode during whole cell recording was usually 3-5 MΩ. Adding PIs or antibodies to pipette solutions did not influence the access resistance. When necessary, the current density was calculated by dividing the macroscopic current by the membrane capacitance, which was obtained using pCLAMP 9.2 software (Axon Instruments). Usually, a period of ~30 min was allowed for cell dialysis after the membrane rupture, and the current recordings were begun thereafter. All experiments were performed at 36.5 ± 0.5°C.
Videomicroscopy and image analysis. The measurement of the cell area on the videomicroscopic image was the same as described previously (36, 39). Briefly, microscopic images captured by a CCD video camera (CS3330; Tokyo Electronic, Tokyo, Japan) were fed into a computer (DELL Dimension 4100; Dell Computer Corporation, Round Rock, TX, USA). Number of the pixels included within the captured cell-image, which was detected by ScionImage software ver.4.03 (Scion), was used as a measure of the cell area. It should be noted that the cell area is only a rough index of the cell volume. The validity of this method to estimate the cell volume has been discussed in the previous paper (36).
Solutions and drugs.
The PSS for cell preparation contained (mM): 126 NaCl, 10 glucose, 4.4 KCl, 5.0 MgCl 2 , 1.5 CaCl 2 , 20 taurine, 5.0 creatine, 5.0 sodium pyruvate, 1.0 NaHPO 4 , 10 Hepes; pH 7.4 adjust with NaOH; 300 mOsm with mannitol. Ca 2+ -free PSS was prepared by simply omitting CaCl 2 from the PSS. The modified KB solution for cell storage contained (mM): 70 potassium glutamate, 20 KCl, 1.0 MgCl 2 , 10 KH 2 PO 4 , 10 taurine, 10 EGTA, 10 glucose, 0.1% albumin, 10 β-hydroxybutric acid and 10 Hepes; pH 7.2 with KOH; 300 mOsm with mannitol. For VRAC currents recording, the isotonic extracellular solutions (ISO) contained (mM): 80 NaCl, 20 TEA-Cl, 1.0 MgCl 2 , 0.5 CaCl 2 , 0.5 BaCl 2 , 0.5 CdCl 2 , 0.01 GdCl 3 , 5.5 glucose, 10 HEPES, 0.01 nicardipine; pH 7.4 with CsOH: 310 mOsm with PI3K (11, 20, 33) , and that the inhibition of PI3K attenuates VRAC current in several cell types (5, 12, 28, 32, 33) . These results may indicate the involvement of PI3K in the activation of VRAC, while the activated PI3K may trigger some downstream signaling cascades, e.g. PI3K/reactive oxygen species (ROS) (26) or PI3K/serum-and glucocorticoid-inducible kinase (SGK) (33) cascade, to activate VRAC. However, the role of PIs, which should strongly depend on PI3K activity, in the activation process of VRAC is not necessarily clear (11, 18) . In the present study, we examined the effect of intracellular PIs (PIP2 and PIP3) on VRAC current in mouse cardiac cells, in an attempt to elucidate the role of these compounds in VRAC activation.
MATERIAL AND METHODS
Cell preparation. Saga University Animal Care and Use Committee approved the use and treatment of all animals used in the experiments described here. The investigation conforms also with the Guiding Principles of the Physiological Society of Japan. Single ventricular cells were isolated from the heart of mice (18-25 g, C57BL/6J/black inbred, male) using an enzymatic dispersion technique (38). Briefly, mice were anaesthetized with sodium pentobarbitone (50 mg mL −1 , i.p.). The chest was opened, and the heart was rapidly removed and perfused, by using a modified Langendorff technique, with a physiological saline solution (PSS, see Solutions and drugs) warmed to 37°C to wash out blood, and then with a nominally Ca 2+ -free PSS until the heart ceased to beat, and finally with Ca 2+ -free solution containing 0.1% collagenase (CLSII; Worthington, Lakewood, NJ, USA) and 1.0% bovine serum albumin (BSA) for 20-30 min. The ventricles were removed and cell dissociation was achieved by gentle mechanical agitation of the tissue in high-K + , lowCl − storage (modified KB) solution (see Solutions and drugs) and the dissociated cells were stored in a refrigerator (4°C) for later use (within 8 h). Only rod-shaped myocytes with clear cross-striations and no blebs were used in the experiments.
Electrophysiological techniques. The tight-seal wholecell patch-clamp technique was used to record whole-cell currents (38). Patch pipettes (1.5 mm O.D. borosilicate glass electrodes) had a tip resistance of 1-3 MΩ when filled with pipette solution. Voltage-clamp recordings were performed using patch-clamp amplifiers (Axopatch 200B; Axon Instruments, Foster City, CA, USA) and membrane cated by (a) and (b) in Fig. 1A . The corresponding current-voltage (I-V) relationships are shown in Fig. 1Bc . The VRAC current was largely timeindependent during the voltage pulses, but a weak time-dependent inactivation was noted at positive potentials (Fig. 1Bb) . The I-V relationship of VRAC current displayed moderate outward rectification with the reversal potentials (E rev ) of about −20 mV (Fig. 1Bc) , of which value was close to the predicted Cl − equilibrium potential (E Cl = −21 mV) under the present condition. These features of VRAC current agree with those reported earlier (5, Fig. 1D summarizes the results of similar experiments performed under various conditions. In this graph, data are expressed as the difference (difference current) between the amplitude of the wholecell current at +100 mV observed 20 min after introduction of HYPO and that observed before HYPO. The suppression of VRAC current was also observed when the pipette solution contained PIP2-Ab, instead of PIP3-Ab, though the suppression by PIP2-Ab appeared to be less than that by PIP3-Ab (Fig. 1D ). The current suppression was not due to the loaded antibody protein itself, since loading of the cells with heat-inactivated antibodies was without effect (Fig. 1D) . Thus, the activation of VRAC current in ventricular cells appeared to require the presence of intracellular PIP3 and/or PIP2. PI3K converts the membrane-bound PIP2 to PIP3, and its inhibition would lead to a decreased level of intracellular PIP3 concentration. We examined the effect of LY294002, a specific inhibitor of PI3K, on VRAC current. As shown in Fig. 2A and D, the development of VRAC current was strongly suppressed in the cells loaded with 10 μM LY294002. The suppression was voltage-independent, i.e. both the inward and outward currents were inhibited ( Fig. 2A) . Similar results were obtained in cells loaded with another PI3K inhibitor, wortmannin (300 nM) (data not shown). These results are in agreement with the previous studies, in which the effect of these inhibitors on VRAC current was examined in rabbit ventricular cells (5, 26) , cultured smooth muscle cells (33) and hepatoma cells (11, 12 (8), and PIP3 dic8 (Echelon Biosciences) (4) were added to the pipette solution. PIP2 and PIP3 were directly dissolved in the control pipette solution at a concentration of 10 μM (4, 8) . PIP2-Ab and PIP3-Ab were used at a 1 : 50 dilution. Heat-inactivated antibodies (100°C for 20 min) were prepared for control when necessary. LY294002 (Sigma) was sometimes added to the pipette solution (final concentration = 10 μM). The osmolarity of all solutions was measured using freezing point depression osmometers (Model OM-801; Vogel, Giessen, Germany) before use.
Data analysis. Data are expressed as mean ± S.E.M.; n indicates the number of cells. Statistical comparisons were performed either by ANOVA with posthoc test (Scheffe's multiple comparison test) for group data or by paired or unpaired Student's t test for comparison of only two groups. A two tailed probability of < 0.05 is taken to indicate statistical significance.
RESULTS
The time-course of changes in the amplitudes of VRAC current observed during hypotonic perfusion in control cells (•) and cells loaded with PIP3-Ab (○) is shown in Fig. 1A . Upon introducing hypotonic solution (HYPO), VRAC current developed and gradually increased reaching an almost steady level in ~15 min in control cells. However, VRAC current developed little or only slightly during hypotonic perfusion in the cells with PIP3-Ab. D, mean density of VRAC current (ΔI, difference current) at +100 mV obtained under various conditions. In this and subsequent similar graphs, VRAC current (ΔI) was obtained by subtracting the current amplitude observed before application of HYPO from that observed 20 min after HYPO. Pipette solution contained PIP3-Ab, heat-inactivated PIP3-Ab, PIP2-Ab, heatinactivated PIP2-Ab or no antibody (Control). * and **: significantly smaller than the value obtained with corresponding heatinactivated antibody at P < 0.05 and 0.01, respectively.
The foregoing results can be interpreted as indicating that the activation of VRAC current during hypotonic perfusion required PI3K-mediated increase in PIP3 level in the cells. We tested whether addition of PIs (10 μM PIP3 and 10 μM PIP2) to the intracellular milieu can influence VRAC current. Loading the cell with PIs appeared to affect little the basal background current (I bb ) observed in isotonic solution (Fig. 2B and C) . Thus, the density of I bb was 2.75 ± 0.30 pA pF −1 (n = 11) in control cells and was 2.78 ± 0.40 pA pF −1 (n = 6) and 2.93 ± 0.27 pA pF −1 (n = 5) in cells loaded for 30 min with 10 μM PIP2 or PIP3, respectively. Similarly, as shown in Fig. 2B , C and D, the magnitude of VRAC current in the cells loaded with these compounds were almost the same as that in control cells, indicating that excess PIs did not enhance the current during hypotonic perfusion. The finding that excess PIP2 had no inhibitory effect on VRAC current ( Fig. 2B and D) may exclude the possibility that the current suppression by PI3K inhibitor ( Fig. 2A) was related to an accumulation of PIP2, if any, due to inhibited phosphorylation reaction. The ineffectiveness of excess PIs on VRAC current was observed also when the solution for VRAC activation was not a highly hypotonic one (200 mOSM, Fig. 2 ) but a mildly hypotonic one (250 mOsm) in which VRAC current was slightly activated (data than PIP2. It is likely that the suppression of this current in cells loaded with PIP2-Ab (Fig. 1D) was indirectly induced by the reduction of PIP3 level which resulted from reduction of its precursor, PIP2. VRAC current is implicated in the development of regulatory volume decrease (RVD) in many types of mammalian cells including cardiac cells (39). We examined the changes in cell volume during hypotonic challenge in the cells in which VRAC current was suppressed. We measured the cell area on captured video image as an index of cell volume. In the presence or absence of LY294002, the cell area increased upon introduction of HYPO, and the increase peaked about 5 min after HYPO (Fig. 4A) . In control cells (black bar in Fig. 4A and closed circles in Fig. 4B ), the cell area spontaneously began to decrease thereafter, exhibiting RVD. In the presence of LY294002 (white bar in Fig. 4A and open circles in not shown). The ineffectiveness of excess PIs on both I bb in isotonic condition and VRAC current during hypotonic challenge suggests that PIs alone without osmotic stimulation do not induce VRAC current and that PI3K-mediated increase in PIP3 level, with or without supplementary PIs, is sufficient to fully activate VRAC current during hypotonic perfusion. The latter view is in line with the notion that PIP3 and PIP2 may be low-abundance membrane phospholipids (3, 22) . To further clarify the roles of PIs and to differentiate the role of PIP2 and PIP3 in VRAC activation, we examined the effect of excess PIs on VRAC current in the cells in which the production of endogenous PIP3 was presumably suppressed. As shown in Fig. 3 , the magnitude of VRAC current was almost normal in the cells co-dialyzed with LY294002 (10 μM) and PIP3 (10 μM). Since loading the cells with the former alone resulted in a definite current suppression ( Fig. 2A and D) , excess PIP3 appeared to restore VRAC current in this case. In contrast, excess PIP2 (10 μM) could not restore the suppressed current (Fig. 3) . The restoring effect of excess PIP3 was observed also in the cells co-dialyzed with PIP2-Ab and 10 μM PIP3 ( Fig. 3 ; refer to the data for PIP2-Ab in Fig. 1D ). Excess PIP2 could not restore the VRAC current suppressed by PIP3-Ab. Thus, excess PIP3, but not excess PIP2, appeared to reverse the attenuated VRAC current in PIP3-or PIP2-depleted cells. We conclude that PIP3 is more directly linked to the activation of VRAC current their effects on PIP3-regulated transporters and channels (4, 8) , further studies are necessary to clarify to what extent PI3K activation can increase the PIP3 level in intact cardiac cells. As with the relationship between cell swelling and PI3K-related signaling pathways, several reports have shown that mechanical stretch of membrane and cell swelling cause activation of PI3K (16) , and the activated PI3K has been suggested to trigger some downstream signaling cascades leading to the activation of VRAC current (5, 7, 26, 33) . For example, Baumgarten and his colleagues (5) showed that ROS production by NADPH oxidase (NOX), which is formed by PI3K-dependent NOX subunits (p47 phox , p67 phox , Rac), was essential for activation of VRAC current in rabbit ventricular cells. Wang et al. (33) showed that the PI3K/SGK cascade was involved in the activation of VRAC current in cultured smooth muscle cells. Then the question may arise as to how PIP3 can be involved in such downstream reactions. In this regard, it is noteworthy that most of these signaling proteins such as GDP-GTP exchange factors for Rac or SGK structurally include PH domains or phox-homology domains, and that PIP3 binds to these domains to transduce intracellular signals (6, 25) . It is possible that similar PIP3-dependent processes are involved in the activation of VRAC current in mouse cardiac cells. Though several types of ion transporters and channels in eukayotic cells have been shown to be directly regulated by PIP2 (14), our results suggest that PIP2 may indirectly influence VRAC current, only acting as a precursor of PIP3 (Figs. 1 and 3) . However, it has been reported that VRAC activity is unaffected by intracellular PIP2-Ab in Ehrlich-Lettre ascites cells (18) . In addition, although PIP3 alone without osmotic stimulation could not induce VRAC current in our study (Fig. 2C) , a spontaneous activation of VRAC-like current was observed in cultured epithelial cells derived from intrahepatic bile duct of the rat when they were dialyzed with PIP3 under isotonic conditions (11) . The reasons for these discrepancies are unknown. Although PIP3 may play a crucial role in the VRAC activation in mouse ventricular cells, our finding that PIP3 alone could not activate VRAC (Fig. 2C ) must be explained. We hypothesize that two distinct membrane stress-dependent processes are required for VRAC activation. One is a change in the state of VRAC and the other is the PI3K/ PIP3-related signaling pathway. The change in the channel state can be a membrane stress-induced transition of VRAC from PIP3-insensitive state to Fig. 4B) , however, the cells did not show any detectable RVD. Re-application of ISO decreased the cell area, which reflected a recovery of cell volume (rightmost data in Fig. 4A) . In control cells, the recovered level of cell area was definitely smaller than the initial level (data for 0 min), showing an excess cell shrinkage. This undershoot of cell volume seen upon reapplication of ISO following exposure to HYPO is a general phenomenon associated with RVD (39). In contrast to control cells, the cells exposed to LY294002 did not show such an undershoot of cell area, which probably reflected the loss of RVD in these cells. RVD of cardiac cells is thought to be caused by the combination of K + flux through inward rectifier K + channel and Cl − flux through VRAC (37, 39). Since LY-294002 is known to little affect the inward rectifier K + channel (Kir2.1) (19) , it is most likely that the inhibition of VRAC current ( Fig. 2A and D) led to the loss of RVD in LY294002-treated cells.
DISCUSSION
This is the first study to demonstrate, in mammalian excitable cells, that PIs contribute to activation of VRAC current, though the activity of PI3K has been implicated in the current activation in several previous studies (see below). Our results using mouse ventricular cells were considered to indicate that the activation of VRAC current requires an increase in the intracellular PIP3 level, that PI3K-mediated increase in PIP3 level is sufficient to fully activate VRAC current in normal cells during hypotonic perfusion, and that PIP3 alone without osmotic stimulation cannot induce VRAC current. The activity of PI3K does not seem to be absolutely necessary for the current activation, because excess PIP3 could restore the current in the cells treated with a PI3K inhibitor (Fig. 3A) . PIP2 appeared to act as a precursor of PIP3 in the activation process of VRAC current. Our results suggest that VRAC current in mouse ventricular cells is regulated by PIP3 and/or its downstream signaling pathways.
The restoration of VRAC current by 10 μM PIP3 (Fig. 3) may not necessarily mean that PIP3 acts on the current system with this concentration range under physiological conditions. An increase of PIP3 up to 2 μM was suggested for activated neutrophils (30), but this change was not related to osmotic stimulation. Although the concentration (10 (29) demonstrated that a sudden increase of cell size by application of positive pressure results in a gradual activation of VRAC current (~500 s for steady-state) in dog atrial cells, and suggested that there is no direct mechanical gating of VRAC and that intracellular signaling pathways might be involved in activation of cardiac VRAC current. This view is in accordance with our hypothesis. However, the whole feature of the signal transduction from cardiac membrane stretch to opening of the VRAC is still uncertain in many points, and its elucidation must await further investigations. We are now extending our study in an attempt to clarify the process of membrane stress-PI3K/PIP3 pathway and its downstream processes responsible for the activation of VRAC current in mouse heart, in consideration of our hypothesis described above. 
